The purpose of this study is to evaluate the safety, efficacy, and maintenance of effect of an investigational medication in people with depression.
You may be eligible to participate if you:
If you are interested, additional eligibility criteria will be assessed by the study doctor or staff.
The study consists of Part 1 and Part 2. In Part 1, you will receive the investigational medication or placebo (contains no active medication) for 6 weeks.
If you complete Part 1, you will have the option to participate in Part 2. In Part 2, you could receive the investigational medication for up to 16 weeks or more.
Qualified patients may receive study-required medical care and investigational study medication at no cost. The study will not pay for other medical care or current medication(s) needed to support your daily health care routine.
Call us at (972) 503-9388
Email us at studies@vastclinicalresearch.com
Janssen Research & Development, LLC
42847922MDD3003-ENG03
Version 1.0, 5Feb2024